Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5314375

CIDOFOVIR
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1.O.O

Basic Information

ChEMBL ID CHEMBL5314375
Name CIDOFOVIR
Phase Approved
Structure Type MOL
InChI Key FPKARFMSZDBYQF-ILKKLZGPSA-N
Therapeutic ✓ Yes
Parent Compound CHEMBL152
Active Moiety CHEMBL4594372

Known Names

Cidofovir Cidofovir dihydrate GS-0504 Hpmpc dihydrate NSC-742135 Vistide
30
Targets
380
Activities
3
Assay Types
16
PK Parameters
20
Publications
6
Known Names
15
Indications
1
Mechanisms

Molecular Properties

279.2
MW (Da)
-1.66
ALogP
7
HBA
4
HBD
147.9
PSA (Ų)
0.45
QED
0
Ro5 Violations
6
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1996
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Parenteral

Flags

Black Box Warning Prodrug
USAN Stem -vir
USAN Year 1994

Extended Properties

Molecular Formula C8H18N3O8P
MW 315.22
Aromatic Rings 1
Heavy Atoms 18
NP-Likeness 0.33

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Human herpesvirus 1 DNA polymerase inhibitor INHIBITOR DNA polymerase catalytic subunit

Indications

Cytomegalovirus Retinitis Primary Immunodeficiency Diseases Virus Diseases Anus Neoplasms Anus Neoplasms Cytomegalovirus Infections Infections Papilloma Sarcoma Uterine Cervical Dysplasia Condylomata Acuminata Herpes Simplex HIV Infections Kidney Diseases Uterine Cervical Neoplasms

ATC Classification

J05AB12
cidofovir
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIVIRALS FOR SYSTEMIC USE

Drug Warnings

Black Box Warning
hematological toxicity
Country: United States
Black Box Warning
teratogenicity
Country: United States
Black Box Warning
carcinogenicity
Country: United States
Black Box Warning
nephrotoxicity
Country: United States

Activity Summary

EC50 324 meas. best 7.4
IC50 55 meas. best 7.22
Kd 1 meas.

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Murid betaherpesvirus 1
CHEMBL613495
EC50 7.4 7.4 40.0 1
Human alphaherpesvirus 3
CHEMBL613132
EC50 7.36 6.4875 44.0 8
Human betaherpesvirus 5
CHEMBL371
EC50 7.35 6.2233 45.0 82
Human betaherpesvirus 5
CHEMBL371
IC50 7.22 6.1057 60.0 21
Human gammaherpesvirus 8
CHEMBL612780
EC50 7.19 7.19 64.0 1
HEL
CHEMBL613888
EC50 6.8 6.2543 160.0 7
Unchecked
CHEMBL612545
EC50 6.47 6.33 340.0 2
Human alphaherpesvirus 1
CHEMBL377
EC50 6.4 5.7159 400.0 63
Cytomegalovirus
CHEMBL613134
EC50 6.37 5.9933 430.0 12
Human gammaherpesvirus 4
CHEMBL613124
EC50 6.32 6.32 480.0 1
NHDF
CHEMBL614200
IC50 6.3 6.3 500.0 1
NON-PROTEIN TARGET
CHEMBL3879801
EC50 6.29 5.0857 510.0 14
Human alphaherpesvirus 2
CHEMBL370
EC50 6.16 5.7529 700.0 34
BK polyomavirus
CHEMBL4888480
EC50 5.96 5.96 1100.0 1
Felid alphaherpesvirus 1
CHEMBL612743
EC50 5.89 5.89 1300.0 1
Human alphaherpesvirus 1
CHEMBL377
IC50 5.75 5.032 1800.0 5
HFF
CHEMBL614071
IC50 5.72 5.1467 1900.0 3
Human adenovirus 2
CHEMBL613715
IC50 5.51 5.51 3100.0 1
Vaccinia virus
CHEMBL613493
EC50 5.5 4.8084 3200.0 51
Cowpox virus
CHEMBL612672
EC50 5.48 4.7921 3300.0 19
Simplexvirus
CHEMBL613316
IC50 5.48 5.48 3300.0 1
Camelpox virus
CHEMBL613332
EC50 5.28 5.1525 5300.0 4
Human adenovirus 2
CHEMBL613715
EC50 5.0 4.745 10000.0 4
MRC5
CHEMBL614181
IC50 5.0 5.0 10000.0 1
Osteoclast-like
CHEMBL614359
IC50 5.0 5.0 10000.0 1
Vaccinia virus
CHEMBL613493
IC50 4.94 4.559 11500.0 10
ADMET
CHEMBL612558
EC50 4.84 4.565 14400.0 4
Simian virus 40
CHEMBL613051
EC50 4.75 4.7267 17800.0 3
Human adenovirus 5
CHEMBL612237
EC50 4.7 4.7 19900.0 2
Macacine alphaherpesvirus 1
CHEMBL3301403
EC50 4.67 4.605 21600.0 2
Human adenovirus 5
CHEMBL612237
IC50 4.62 4.62 24060.0 1
HFF
CHEMBL614071
EC50 4.57 4.495 27000.0 2
NON-PROTEIN TARGET
CHEMBL3879801
IC50 4.52 4.52 30000.0 2
Ectromelia virus
CHEMBL5291666
IC50 4.47 4.47 33980.0 1
Cowpox virus
CHEMBL612672
IC50 4.33 4.325 46380.0 2
Solute carrier family 22 member 6
CHEMBL1641347
IC50 4.22 4.22 60000.0 1
ME-180
CHEMBL1075499
EC50 4.19 4.19 64700.0 1
Jurkat
CHEMBL397
IC50 4.0 4.0 100000.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC 20101.68 ng.hr.mL-1 -
AUC 335028.0 ng.hr.mL-1 -
AUC 14400.0 ng.hr.mL-1 Macaca fascicularis
AUC 143503.66 ng.hr.mL-1 Macaca fascicularis
AUC 172204.39 ng.hr.mL-1 Macaca fascicularis
AUC 28700.73 ng.hr.mL-1 Macaca fascicularis
AUC 20939.25 ng.hr.mL-1 Homo sapiens
CL 2.5 mL.min-1.kg-1 Homo sapiens
CL 2.5 mL.min-1.kg-1 Homo sapiens
CL 0.3 mL.min-1.kg-1 Homo sapiens
CL 2.5 mL.min-1.kg-1 Homo sapiens
F 2.0 % Homo sapiens
Fu 1.0 - Homo sapiens
Fu 1.0 - Homo sapiens
MRT 3.3 hr Homo sapiens
T1/2 2.6 hr Homo sapiens

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Murid betaherpesvirus 1 EC50 = 40.0 nM 7.4 Antiviral activity against MCMV Smith replication 16539388
Human alphaherpesvirus 3 EC50 = 44.0 nM 7.36 Antiviral activity against VZV OKA expressing thymidine kinase infected in human... 21128666
Human betaherpesvirus 5 EC50 = 45.0 nM 7.35 Antiviral activity against foscarnet-resistant HCMV AD169 clone C infected in HE... 19226140
Human betaherpesvirus 5 IC50 = 60.0 nM 7.22 Antiviral activity against Human cytomegalovirus 19112024
Human gammaherpesvirus 8 EC50 = 64.0 nM 7.19 Antiviral activity against Human herpesvirus 8 infected in human BCBL1 cells ass... 19770274
Human alphaherpesvirus 3 EC50 = 70.0 nM 7.16 Antiviral activity against thymidine kinase-deficient VZV 07/1 infected in human... 21128666
Human betaherpesvirus 5 EC50 = 69.0 nM 7.16 Antiviral activity against wild type HCMV Davis infected in HEL cells assessed a... 19226140
Human betaherpesvirus 5 EC50 = 76.0 nM 7.12 Antiviral activity against wild type HCMV AD169 infected in HEL cells assessed a... 19226140
Human betaherpesvirus 5 EC50 = 92.0 nM 7.04 Antiviral activity against PMEDAP-resistant HCMV AD169 clone 4 infected in HEL c... 19226140
Human betaherpesvirus 5 EC50 = 95.0 nM 7.02 Antiviral activity against acyclovir-resistant HCMV AD169 clone 1 infected in HE... 19226140
Human alphaherpesvirus 3 EC50 = 100.0 nM 7.0 Antiviral activity against thymidine kinase-deficient Varicella-zoster virus 07/... 21745746
Human alphaherpesvirus 3 EC50 = 100.0 nM 7.0 Antiviral activity against VZV 07/1 infected in HEL cells assessed as protection... 21565516
Human betaherpesvirus 5 EC50 = 102.0 nM 6.99 Antiviral activity against Human cytomegalovirus Davis infected in HEL cells ass... 22459876
Human betaherpesvirus 5 IC50 = 110.0 nM 6.96 Antiviral activity against Human cytomegalovirus Towne infected in HFF cells ass... 21641218
Human betaherpesvirus 5 EC50 = 110.0 nM 6.96 Antiviral activity against acyclovir-resistant VZV 07/1 infected in HEL assessed... 20809641
Human betaherpesvirus 5 EC50 = 130.0 nM 6.89 Antiviral activity against acyclovir-resistant VZV OKA infected in HEL assessed ... 20809641
HEL EC50 = 160.0 nM 6.8 Effective concentration against human cytomegalovirus AD-169 strain in HEL cell ... 15081019
Human betaherpesvirus 5 IC50 = 200.0 nM 6.7 Antiviral activity against Human CMV T2211 in HFF cells by SEAP assay 17043128
Human betaherpesvirus 5 EC50 = 220.0 nM 6.66 Antiviral activity against Cytomegalovirus CMV T2211 infected in HFF cells by SE... 17709468
Human betaherpesvirus 5 EC50 = 250.0 nM 6.6 Antiviral activity against HCMV Davis infected in HELF cells assessed as reducti... 36332548

Literature References

PubMed DOI Target Context # Activities
16472241 10.2174/1570163043334794 Hepatotoxicity 18
27933957 10.1021/acs.jmedchem.6b00659 Unchecked 16
17116683 10.1128/aac.00879-06 Mus musculus 15
2544723 10.1021/jm00127a010 Cavia porcellus 15
19029322 10.1128/aac.01257-08 Vaccinia virus 15
22194678 10.1371/journal.pcbi.1002310 Hepatotoxicity 14
18852271 10.1128/aac.00708-08 Vaccinia virus 13
19029322 10.1128/aac.01257-08 Cowpox virus 13
17043128 10.1128/aac.00633-06 Human betaherpesvirus 5 13
17893157 10.1128/aac.00838-07 Camelpox virus 12
28408228 10.1016/j.bmcl.2017.03.100 Human alphaherpesvirus 1 12
2544723 10.1021/jm00127a010 Mus musculus 12
19226140 10.1021/jm8014662 Human betaherpesvirus 5 10
21745746 10.1016/j.bmc.2011.06.045 Unchecked 10
17709468 10.1128/aac.00736-07 Human betaherpesvirus 5 9
17846137 10.1128/aac.00184-07 Vaccinia virus 9
17724153 10.1128/aac.00762-07 Cowpox virus 9
20070106 10.1021/jm901371v Homo sapiens 8
- 10.1016/0960-894X(95)00278-2 HEL 8
18707089 10.1021/jm800050t Human betaherpesvirus 5 8

Data from ChEMBL 36 via Core Engine